• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Transgenomic Inc

+ Add to Watchlist

TBIO:US

2.2000 USD 0.3500 18.92%

As of 20:10:00 ET on 12/19/2014.

Snapshot for Transgenomic Inc (TBIO)

Open: 1.8000 Day's Range: 1.7420 - 2.8700 Volume: 281,869
Previous Close: 1.8500 52wk Range: 1.4100 - 6.5400 1-Yr Rtn: -59.26%

Stock Chart for TBIO

No chart data available.
  • TBIO:US 2.2000
  • 1D
  • 1M
  • 1Y
1.8500
Interactive TBIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TBIO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.6300
Est. EPS (USD) (12/2014) -1.9000
Est. PEG Ratio -
Market Cap (M USD) 17.79
Shares Outstanding (M) 8.08
30 Day Average Volume 52,991
Price/Book (mrq) 1.5872
Price/Sale (ttm) 0.8128
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TBIO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TBIO

Transgenomic, Inc. provides research tools to the life sciences industry. These tools enable researchers to discover and understand variation in the human genetic code, or genome, in order to accelerate and improve drug development and diagnostics.

Paul KinnonPresident/CEO/Interim CFO/SecyLeon RichardsChief Acctg Officer/Controller
More Company Profile & Key Executives for TBIO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil